⌘K

Home/Filings/4/0001104659-22-077837

4//SEC Filing

Androski Lindsay 4

Accession 0001104659-22-077837

CIK 0001035354other

View on SEC.gov Company Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 9:50 PM ET

Size

5.7 KB

Accession

0001104659-22-077837

Insider Transaction Report

Form 4

Period: 2022-07-01

Eloxx Pharmaceuticals, Inc.ELOX

Androski Lindsay

Director

Transactions

Award
Stock Options (Right to Buy)
2022-07-01+40,000→ 40,000 total
Exercise: $0.25Exp: 2032-07-01→ Common Stock (40,000 underlying)

Footnotes (1)

[F1]The stock option vests as to 50% of the underlying shares on July 1, 2023 and the remainder in twelve (12) equal monthly installments thereafter.

Documents

1 file

4
tm2220578-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Eloxx Pharmaceuticals, Inc.

CIK 0001035354

Entity typeother

Related Parties

1

filerCIK 0001936604

Filing Metadata

Form type: 4
Filed: Jul 5, 8:00 PM ET
Accepted: Jul 6, 9:50 PM ET
Size: 5.7 KB

View on SEC.gov